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Abstract
Background: The type of silhouette and quantity of fat tissue are correlated with hormonal imbalance which plays
a substantial role in breast carcinogenesis. The goal of the study was to investigate the association between various
anthropometric characteristics and breast cancer risk.
Methods: Detailed anthropometric assessment was conducted on 487 women of whom 193 had diagnosed
breast cancer and were consecutive patients in the Oncology Center, Cracow, Poland between 2002 and
2004. Measurements were divided into four categories: overall body size (body mass index [BMI], waist
circumference [WC], waist-hip ratio [WHR]), regional body sizes (skinfold thicknesses, circumferences), thickness
of the skeleton (widths, chest diameters), and body proportions. Additionally, results were analyzed in regard
to menopausal status. Differences between groups were assessed using Student’s t test and Mann-Whitney’s
test. Models of logistic regression for selected data were built to estimate the odds ratio. Results were
considered statistically significant when the P value was less than 0.05.
Results: The BMI in both groups was negatively associated with the risk of cancer. Among premenopausal
women, WHR increased the risk of breast cancer (WHR > 0.83, OR, 2.72; 95 % CI, 1.01–7.27). Anthropometric
indices of hip-to-shoulder ratio in postmenopausal (≥84.2 mm, OR, 0.02; 95 % CI, 0.01–0.11) and trunk-to-height
ratio in both premenopausal women (≥32.76, OR, 0.09; 95 % CI, 0.03–0.28) and postmenopausal women (≥32.76,
OR, 0.13; 95 % CI, 0.05–0.33) were strongly related to a decreased risk of breast cancer. Thicknesses of the triceps
and subscapular skinfolds increased the risk of breast cancer.
Conclusions: Women with breast cancer present with an obese type of silhouette with a specific concentration
of fat tissue in the central and upper parts of the body.
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Background
There are many studies which confirm that breast
cancer is strongly associated with body size [1–7].
Characteristics which are generally taken into account
when assessing body shape include height, weight, body
mass index (BMI), waist-hip ratio (WHR), and waist
circumference (WC) [1–5, 8, 9]. All these measurements
are found to be correlated with menopausal status,
and their value is linked to estrogen and androgen
levels [10–14]. However, results of different studies
remain discordant.
Notably, peripheral fat tissue plays a substantial role in
the synthesis of sex steroid hormones in women. Thus,
after menopausal transition, obesity leads to a higher
level of estrogen and androgens which are mitogenic
agents for breast cells. Equally, it has been found that
the moment of diagnosis of breast cancer in obese
women is delayed and chemotherapy is less efficient [15].
Moreover, obesity is a sign of bad dietary habits and lack
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of physical activity which are considered as risk factors in
breast carcinogenesis [16].
The question remains whether there are any different
features in the body silhouette which may exemplify
hormonal imbalance in women with breast cancer. In
this aim, we conducted detailed anthropometric studies
of 488 women of whom 193 had diagnosed breast
cancer. The parameters which we considered may be
divided into four categories: overall body size (BMI, WC,
WHR), regional body sizes (skinfold thickness, circumfer-
ences), thickness of the skeleton (widths, chest diameters),
and body proportions.
We compared our results with different studies; how-
ever, thickness of the skeleton and body proportions
have not hitherto been described in the literature. We
also hypothesized that body composition differences in
breast cancer women are only a symptom of different
metabolic and biochemical disturbances. Therefore, cer-
tain anthropometric measurements could be helpful in
identifying women at a higher risk of developing breast
cancer in the future.
Material and methods
We performed a case-control population study based on
488 women—193 cases and 295 control subjects. The
manuscript submitted for publication contains an ex-
periment which complies with the current law of Poland
where it was performed and was approved by the Ethics
Committee Board in Cracow, Poland.
Participants
All cases were collected from the Oncology Center,
Cracow, Poland. We included patients aged between 35
and 80 years old with newly diagnosed breast cancer and
who were qualified for radical mastectomy during the
period of 2002–2004. Each patient’s diagnosis was
confirmed by pathologists. We excluded patients with a
previous history of cancer, after neoadjuvant treatment,
pregnant, breastfeeding, or with liver disease. Female
controls were chosen randomly from local industry
companies, public education institutes, and social service
workers. Cancer-free participants were matched to
patients by age and sex to eliminate the most im-
portant confounding factors.
Data collection
Data were collected anonymously and consent from all
participants was obtained orally. After taking all mea-
surements, each patient signed up on a questionnaire as
an approval of participation in the study.
All participants were interviewed by students and
the authors in person at the hospital and workplace
and via a structured questionnaire to obtain such in-
formation as demographic factors, menstrual status,
reproductive history with a detailed history of breast
feeding, and family history of cancer. Menopause was
defined as no menses for 12 months or bilateral
oophorectomy or hysterectomy.
Anthropometric measurements were directly taken in
accordance with International Standards for Anthropo-
metric Assessment [17] by trained interviewers with (1)
digital scales to measure weight (without clothes and
shoes); (2) a large anthropometer (which measures
between 0 and 60 cm in 0.1-cm increments) to localize
specific anthropometric marks (such as basion, vertex,
symphysion, lumbal, acromial, iliocristal, and supraster-
nal marks); (3) Martin breadth calipers to measure hip
width (biiliocristal diameter between the outer edges of
the iliac crest); shoulder width (biacromial diameter);
wrist, elbow, knee, and ankle widths (all measurements
were taken at midpoints); and arm width (at a mid-acro-
miale-radiale point); (4) chest depth caliper to meas-
ure transverse and sagittal chest diameter (at nipple
level); (5) anthropometric non-stretchable tape to
measure height (without shoes, looking straight ahead,
with shoulders down, with participants standing next to
the wall), waist circumference (at the midpoint between
the lower margin of the last palpable rib and the top of
the iliac crest), hip circumference (at the widest part of
the buttocks on the level of greater trochanter), neck cir-
cumference (on the level of the laryngeal prominence),
and arm, thigh, and wrist circumferences at midpoints;
and (6) skinfold caliper to measure triceps skinfold thick-
ness (at the midpoint of the back of the upper arm),
subscapular skinfold thickness (at the lower angle of the
scapula), suprailiac skinfold thickness (at the one quarter
of the distance between the navel and anterior superior
iliac spine), and calf skinfold thickness (at midpoint). In
order to take the mentioned measurements, we used
Mikropolis’ anthropometric measuring kit.
To estimate body proportion, we calculated body mass
index (BMI by dividing weight [kg] with the square of
height [m]), waist-to-hip ratio (WHR), and additional
anthropometric indexes such as the length of the trunk
(from suprasternal mark to symphysion), hip-to-shoulder
ratio, hip-to-height ratio, shoulder-to-height ratio, and
trunk-to-height ratio.
Data analysis
All statistical analyses were stratified according to meno-
pausal status. To evaluate differences between cases and
control participants, Student’s t test and Mann-Whitney’s
test were conducted for demographic factors, reproductive
history and all taken anthropometric measurements. We
performed the analysis for normal distribution for every
single measurement, and then, we used a t test for param-
eters presenting normal distribution (namely thigh cir-
cumference, arm width, wrist width) and Mann-Whitney
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U test for these parameters which did not qualify for
the t test (the rest of the parameters). Furthermore,
logistic regression analysis was performed for the fol-
lowing anthropometric factors: hip-to-shoulder ratio;
trunk-to-height ratio; suprailiac, triceps, and subscap-
ular skinfold thicknesses; and wrist circumference and
for BMI and WHR ratios to obtain the odds ratios
(OR) with 95 % confidence intervals. To observe the
dose-response effect, we categorized all these variables
into quartile groups. Additionally, we adjusted each ana-
lysis for age, education status, and potential confounders:
positive family history of breast cancer, age at menarche,
number of parity, and age of menopause for the postmen-
opausal group. All analyses were performed using STA-
TISTICA 10.0. Results were considered statistically
significant when the P value was less than 0.05.
Results
Analysis of the baseline characteristic of the groups
(Table 1) showed statistically significant differences
between all participants in age at enrollment, age at last
birth, number of parity, family history of breast cancer
in first-degree relatives, and number of miscarriages.
Patients with breast cancer were significantly older than
cancer-free women (56.2 ± 11.8 vs 50.4 ± 13.2 years,
P < 0.01) and were older at the time of the birth of
their last offspring (30.1 ± 6.1 vs 28.2 ± 4.9 years, P < 0.01).
They had a greater number of parity (2.0 ± 1.4 vs 1.5 ± 1.1,
P < 0.01) and more episodes of miscarriages (0.7 ± 2.2 vs
0.4 ± 0.7, P < 0.01). A positive family history of breast
cancer in first-degree relatives was reported more often by
healthy individuals (83 vs 26, P < 0.01). We did not
observe any statistical differences regarding age at menar-
che, age at first birth, education, and age at menopause.
In the group of premenopausal participants, significant
differences were observed only in age at enrollment
because of the greater number of participants in the
control group (cases were older than controls 45.1 ± 5.3
vs 41.8 ± 6.1 years, P < 0.01). In postmenopausal partici-
pants, there were no differences in age and the only
statistically significant differences were connected with
the number of parity (2.1 ± 1.4 cases vs 1.5 ± 1.3
controls, P < 0.01) and with a positive family history of
breast cancer (16 cases vs 34 controls, P < 0.01).
An analysis of anthropometric measurements (Table 2)
showed a number of differences in the body structure
between women with breast cancer and healthy partici-
pants. A comparison without stratification according to
menopausal status revealed that cancer participants had
greater chest—transverse and sagittal—diameters; thigh,
wrist, and waist circumferences; wrist, elbow, ankle, and
arm widths; and triceps, subscapular, and calf skinfold
thicknesses measurements. Measurements of pelvis diam-
eters and length of trunk were significantly lower. Estima-
tion of body proportions revealed that women with breast
cancer have narrower pelvises, broader shoulders, and
shorter trunks compared to their height.
Among premenopausal woman with breast cancer, we
observed significantly higher measurements in shoulders,
elbow, ankle, arm, transverse chest diameter, wrist and
Table 1 Comparison of cases and controls on demographics and selected breast cancer risk factors
Premenopausal women Postmenopausal women All women
n = 239 n = 248
Cases (61)
mean value
(SD)
Controls (178)
mean value
(SD)
P value Cases (132)
mean value
(SD)
Controls (116)
mean value
(SD)
P value Cases (193)
mean value
(SD)
Controls (294)
mean value
(SD)
P value
Age at enrollment (years) 45.1 (5.3) 41.8 (6.1) <0.01 61.4 (10.4) 63.4 (10.2) 0.2 56.2 (11.8) 50.4 (13.2) <0.01
Age at menarche (years) 14.0 (1.6) 13.9 (1.4) 0.7 14.1 (1.6) 14.1 (1.9) 0.7 14.1 (1.6) 14.0 (1.6) 0.8
Age at first birth (years) 24.4 (4.5) 24.2 (4.1) 1.0 24.7 (4.3) 24.6 (4.5) 0.7 24.6 (4.4) 24.3 (4.2) 0.6
Age at last birth (years) 29.3 (7.1) 27.7 (1.9) 0.7 30.5 (5.5) 29.5 (5.1) 0.3 30.1 (6.1) 28.2 (4.9) <0.01
Number of parity 1.9 (1.3) 1.5 (0.9) 0.7 2.1 (1.4) 1.5 (1.3) <0.01 2.0 (1.4) 1.5 (1.1) <0.01
Family history of
breast cancer in
first-degree relatives
10 49 0.07 16 34 <0.01 26 83 <0.01
Education 0.29 0.13 <0.01
Primary 15 33 57 34 72 67
Vocational 7 31 5 8 12 39
Secondary 21 47 49 48 70 94
Higher 18 67 21 25 39 92
Number of miscarriages 1.0 (3.7) 0.3 (0.7) 0.1 0.6 (1.0) 0.5 (0.8) 0.4 0.7 (2.2) 0.4 (0.7) <0.01
Age at menopause (years) – – – 48.7 (5.2) 49.5 (4.7) 0.8 48.7 (5.2) 49.5 (4.7) 0.8
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Table 2 Comparison of anthropometric measurements of cases and controls
Premenopausal women Postmenopausal women All women
n = 239 n = 248 n = 487
Cases (61) mean
value (SD)
Controls (178)
mean value (SD)
P value Cases (132) mean
value (SD)
Controls (116)
mean value (SD)
P value Cases mean
value (SD)
Controls mean
value (SD)
P value
Overall body size
Body mass (kg) 67.98 (13.06) 65.45 (12.16) 0.28 69.47 (12.24) 70.18 (12.11) 0.71 69.0 (12.49) 67.32 (12.34) 0.14
Height (m) 1.59 (0.06) 1.59 (0.06) 0.38 1.56 (0.06) 1.55 (0.06) 0.20 1.57 (0.06) 1.58 (0.06) 0.16
WHR 0.80 (0.05) 0.76 (0.05) <0.01 0.81 (0.05) 0.81 (0.07) 0.21 0.81 (0.05) 0.78 (0.07) <0.01
BMI 27.14 (5.96) 25.59 (4.78) 0.26 28.48 (4.54) 29.14 (4.46) 0.99 28.07 (5.06) 26.99 (4.96) 0.05
Waist circumference (cm) 82.21 (10.68) 78.92 (10.53) 0.05 87.06 (10.61) 89.25 (12.0) 0.30 85.52 (10.84) 82.99 (12.21) <0.01
Hip circumference (cm) 103.23 (9.46) 103.53 (9.07) 0.85 106.86 (10.75) 109.5 (10.13) 0.08 105.71 (10.47) 105.89 (9.93) 0.95
Regional body sizes
Arm circumference (cm) 29.19 (4.24) 28.87 (3.34) 0.87 30.05 (3.64) 31.12 (3.74) 0.03 29.78 (3.85) 29.76 (3.67) 0.66
Thigh circumference (cm) 56.13 (5.2) 54.58 (5.31) 0.05 55.70 (5.12) 53.59 (6.56) 0.01 55.83 (5.13) 54.19 (5.83) <0.01
Wrist circumference (cm) 16.26 (1.06) 15.91 (0.92) 0.02 16.95 (1.08) 16.55 (1.14) 0.01 16.72 (1.12) 16.16 (1.06) <0.01
Neck circumference (cm) 34.58 (2.87) 35.61 (2.21) 0.21 35.02 (2.47) 35.45 (2.35) 0.29 34.88 (2.6) 35.54 (18.0) 0.10
Triceps skinfold thickness (mm) 30.50 (9.39) 24.52 (7.4) <0.01 30.03 (8.96) 27.84 (7.46) 0.21 30.19 (9.07) 25.84 (7.59) <0.01
Subscapular skinfold thickness (mm) 32.32 (12.68) 29.42 (11.44) 0.12 35.35 (11.06) 33.72 (12.51) 0.08 34.4 (11.65) 31.12 (12.04) <0.01
Suprailiac skinfold thickness (mm) 34.35 (12.81) 34.06 (14.05) 0.88 38.57 (11.7) 42.73 (15.44) 0.09 37.23 (12.19) 37.49 (15.2) 0.80
Calf skinfold thickness (mm) 20.44 (5.74) 17.87 (4.62) 0.02 19.88 (5.22) 18.97 (5.24) 0.33 20.04 (5.35) 18.3 (4.89) 0.01
Thickness of the skeleton
Hip width (biiliocristal) (mm) 59.35 (3.81) 58.05 (4.6) 0.04 61.04 (5.64) 62.73 (5.23) 0.02 60.52 (5.19) 59.9 (5.36) 0.08
Shoulder width (biacromial) (mm) 76.53 (4.65) 73.86 (4.84) <0.01 76.50 (6.38) 73.35 (5.33) <0.01 76.51 (5.88) 73.66 (5.04) <0.01
Wrist width (mm) 52.54 (2.97) 51.66 (3.1) 0.17 54.07 (3.18) 53.77 (3.4) 0.58 53.6 (3.18) 52.48 (3.38) 0.01
Elbow width (mm) 71.80 (7.46) 64.38 (5.1) <0.01 72.50 (9.93) 66.84 (5.76) <0.01 72.31 (9.28) 65.36 (5.5) <0.01
Knee width (mm) 93.81 (9.53) 92.78 (6.73) 0.32 97.03 (8.89) 96.79 (8.1) 0.83 96.03 (9.16) 94.32 (7.53) 0.07
Ankle width (mm) 66.13 (3.47) 63.90 (3.67) <0.01 66.59 (4.08) 64.96 (3.84) 0.01 66.45 (3.88) 64.31 (3.77) <0.01
Arm width (mm) 76.29 (3.55) 74.51 (3.86) <0.01 77.60 (3.76) 74.88 (3.9) <0.01 77.19 (3.74) 74.65 (3.87) <0.01
Transverse chest diameter (mm) 278.25 (21.52) 267.13 (20.92) <0.01 276.61 (21.16) 275.27 (23.11) 0.63 277.13 (21.22) 270.34 (22.13) <0.01
Sagittal chest diameter (mm) 202.92 (23.28) 198.76 (21.96) 0.33 218.16 (23.14) 219.87 (23.04) 0.76 213.37 (24.18) 207.09 (24.62) <0.01
Maximal pelvis diameter (mm) 342.20 (25.4) 346.52 (28.98) 0.30 345.36 (23.39) 362.64 (27.87) <0.01 344.37 (24.02) 352.88 (29.57) <0.01
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Table 2 Comparison of anthropometric measurements of cases and controls (Continued)
Body proportions
Length of trunk (mm) 487.02 (26.72) 503.22 (36.71) <0.01 489.60 (70.27) 500.81 (36.56) <0.01 488.79 (60.14) 502.27 (36.61) <0.01
Hip-to-shoulder ratio 77.55 (4.74) 78.74 (6.04) 0.24 79.97 (5.86) 85.69 (6.46) <0.01 79.21 (5.63) 81.48 (7.07) <0.01
Hip-to-height ratio 18.20 (1.55) 18.29 (1.42) 0.44 18.99 (1.35) 20.20 (1.51) <0.01 18.74 (1.46) 19.04 (1.73) 0.05
Shoulder-to-height ratio 23.44 (1.33) 23.25 (1.06) 0.20 23.78 (1.16) 23.6 (1.08) 0.26 23.67 (1.23) 23.39 (1.08) <0.01
Trunk-to-height ratio 30.69 (1.96) 31.57 (2.09) <0.01 31.39 (4.72) 32.29 (2.06) <0.01 31.17 (4.07) 31.86 (2.11) <0.01
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thigh circumferences, triceps skinfold thicknesses, calf
skinfold thicknesses, and WHR. While in the group of
postmenopausal women with breast cancer, we found
significant differences in shoulder, arm, elbow, pelvis, and
ankle breadths and thigh and wrist circumferences and
they presented with broader arms and shorter trunks.
It seems that hip width, suprailiac skinfold thickness,
and arm and neck circumferences are not correlated
either with menopausal status or breast cancer.
Among premenopausal women, WHR was associated
with an increased risk of breast cancer (between subjects
in the highest quartile WHR> 0.83, adjusted OR, 2.72;
95 % CI, 1.01–7.27). However, in postmenopausal women,
there was no linear association between WHR value and
cancer risk. BMI in both groups was negatively asso-
ciated with cancer risk; nevertheless, OR values were
not statistically significant (Table 3).
We also observed a significant impact of the hip-
to-shoulder ratio on cancer risk in postmenopausal
women. High values of this factor were strongly associated
with a decreased risk of breast cancer (in the last
quartile ≥84.2, adjusted OR, 0.02; 95 % CI, 0.01–0.11).
Furthermore, increased trunk-to-height ratio was also
significantly associated with a decreased risk of breast
cancer among both premenopausal women (in the last
quartile ≥32.76, adjusted OR, 0.09; 95 % CI, 0.03–0.28)
and postmenopausal women (in the last quartile ≥32.76,
adjusted OR, 0.13; 95 % CI, 0.05–0.33). Thicknesses of
triceps and subscapular skinfolds were associated with an
increased risk of breast cancer, and wrist circumference
was associated with a decreased risk; however, these
factors did not reach statistical significance (Table 3).
Discussion
The link between anthropometric measurements and
breast cancer risk in different studies remains uncertain
[1–7]. In addition, results are influenced by multiple fac-
tors such as ethnicity, lifestyle, and reproductive status [6].
Overall, it is well established that obesity has an impact on
breast cancer occurrence. It is important to distinguish two
types of obesity—android (WHR> 0.8) in which fat is
mainly distributed in the upper body (shoulders, abdomen)
and gynoid (WHR < 0.8) where fat accumulates in the lower
part of the body (buttocks, thighs) [18]. In persons with an-
droid obesity, metabolic and hormonal abnormalities are
more pronounced.
In our data, pre- and postmenopausal women are
overweight (with BMI > 25 kg/m2) without statistically
significant differences between groups. According to our
investigations, central obesity increases the risk of devel-
oping breast cancer in premenopausal women—these
data are consistent with previous studies [1–3, 7, 17].
However, conversely to previous reports [2–5, 7], in post-
menopausal women, its effect is neutral. It may be due to
a general tendency toward android obesity in elderly
women caused by decreasing levels of estrogen. Despite
these factors, bad dietary habits and a lack of physical
activity after menopausal transition also lead to visceral
obesity.
In postmenopausal women, peripheral adipocytes are
the source of all estrogens which are synthesized from
the conversion of androstenedione. It means that general
obesity is directly linked to an increased level of mito-
genic factors within cancer cells [8, 10, 19]. Obese pre-
menopausal women have lower estrogen levels due to
the storage of estrogen in fatty tissue, decrease in ovar-
ian activity, and frequent anovulatory cycles [1, 2]. Thus,
general obesity is considered as a protection for breast
cancer in premenopausal women. In contrast to previous
investigations [3–7, 20], our study did not reveal a cor-
relation between BMI and the risk of breast cancer or
any statistical differences in BMI among both pre- and
postmenopausal women.
The harmful effect of central obesity remains complex.
This type of obesity is correlated with insulin resistance, in-
creased level of insulin-like growth factor (IGF)-1, and fatty
acids [2, 3, 7, 8, 21]. Insulin inhibits hepatic production of
sex hormone-binding globulin (SHBG), elevates leptin
levels, and diminishes adiponectin levels (both with angio-
genic effect) [22]. Furthermore, insulin modulates VEGF
expression [3, 15]. Together, these substances promote
mammary carcinogenesis by accelerating cell divisions
and inducing the synthesis of transcriptional factors.
Obesity also induces “smoldering” inflammation caus-
ing a permanently elevated level of cytokines (TNF
alpha, IL-6, CRP) which promote tumurigenesis [18,
22, 23].
In regard to body shape, women with breast cancer
present an android type of silhouette with the distribu-
tion of fat tissue in the central and upper parts of the
body which is revealed by increased shoulder width,
waist circumference, skinfold thickness of the triceps
and scapula, and differences in body proportions. An-
thropometric indicators showed that women with breast
cancer have narrower hips and shorter trunks and are
shorter with broader arms—features which are typical
for men. In premenopausal women, such characteristics
are not so evident; however, they deteriorate after meno-
pause. This is due to the high level of androgens
postmenopause caused by a stimulation of androgen
synthesis by IGF-1 in ovarian theca cells and a lower
level of SHBG. It has been stated that the level of
free testosterone increases with BMI [8, 10, 13] espe-
cially in android obesity [18, 24]. Androgens may
promote growth by directly binding to the androgen
receptors or estrogen receptors in breast tissue or
via conversion to estrogen in either peripheral or
breast fat tissue [14].
Pacholczak et al. Journal of Physiological Anthropology  (2016) 35:7 Page 6 of 10
Table 3 Association between anthropometric measurements and breast cancer risk
Premenopausal Postmenopausal All women
Cases Controls OR (95 % CI) P value Cases Controls OR (95 % CI) P value Cases Controls OR (95 % CI) P value
No. Percent No. Percent No. Percent No. Percent No. Percent No. Percent
BMI
<23.8 20 33.9 64 36.0 1.0 (reference) 23 17.5 14 12.1 1.0 (reference) 43 22.6 78 26.5 1.0 (reference)
≥23.9–<27.4 17 28.8 58 32.6 0.68 (0.31–1.50) 0.3 30 22.9 25 21.5 0.64 (0.25–1.62) 0.3 47 24.7 83 28.2 0.73 (0.42–1.27) 0.3
≥27.4–<30.3 10 17.0 31 17.4 0.61 (0.23–1.58) 0.1 34 26.0 39 22.6 0.49 (0.20–1.19) 0.3 44 23.2 70 23.8 0.61 (0.34–1.11) 0.1
≥30.3 12 20.3 25 14.0 0.70 (0.26–1.90) 0.1 44 33.6 38 32.8 0.49 (0.20–1.19) 0.5 56 29.5 63 21.5 0.72 (0.40–1.31) 0.3
WHR
<0.75 10 17.8 74 41.8 1.0 (reference) 7 5.8 21 18.1 1.0 (reference) 17 9.6 95 32.4 1.0 (reference)
≥0.75–<0.79 15 26.8 56 31.6 1.04 (0.43–2.53) 0.9 28 23.1 20 17.2 1.65 (0.66–4.12) 0.3 43 24.3 76 25.9 1.51 (0.84–2.70) 0.2
≥0.79–<0.83 16 28.6 28 15.8 2.01 (0.78–5.18) 0.1 42 34.7 29 25.0 1.81 (0.76–4.35) 0.2 58 32.8 57 19.5 2.25 (1.23–4.13) 0.01
≥0.83 15 26.8 19 10.8 2.72 (1.01–7.27) 0.04 44 36.4 46 39.7 0.97 (0.42–2.24) 0.9 59 33.3 65 22.2 1.50 (0.81–2.76) 0.2
Hip-to-shoulder ratio
<75.9 21 35.0 64 36.0 1.0 (reference) 34 26.0 2 1.7 1.0 (reference) 55 28.8 66 22.4 1.0 (reference)
≥75.9–<80.3 24 40.0 50 28.1 1.19 (0.56–2.54) 0.6 32 24.4 17 14.7 0.10 (0.02–0.50) 0.01 56 29.3 67 22.8 0.69 (0.39–1.22) 0.2
≥80.3–<84.2 11 18.3 37 20.8 0.61 (0.24–1.52) 0.3 38 29.0 35 30.2 0.06 (0.01–0.30) 0.01 49 25.7 72 24.5 0.42 (0.23–0.75) 0.01
≥84.2 4 6.7 27 15.2 0.35 (0.10–1.25) 0.1 27 20.6 62 53.4 0.02 (0.01–0.11) 0.01 31 16.2 89 30.3 0.14 (0.08–0.30) 0.01
Trunk-to-height ratio
<30.17 25 42.4 41 23.0 1.0 (reference) 39 29.8 15 12..9 1.0 (reference) 64 33.7 56 19.0 1.0 (reference)
≥30.17–<31.28 11 18.6 45 25.3 0.28 (0.11–0.70) 0.01 37 28.2 28 24.2 0.45 (0.20–1.04) 0.06 48 25.3 73 24.8 0.45 (0.26–0.79) 0.01
≥31.28–<32.76 15 25.4 43 24.2 0.25 (0.10–0.64) 0.01 36 27.5 29 25.0 0.35 (0.15–0.82) 0.02 51 26.8 72 24.5 0.41 (0.24–0.74) 0.01
≥32.76 8 13.6 49 27.5 0.09 (0.03–0.28) 0.01 19 14.5 44 37.9 0.13 (0.05–0.33) 0.01 27 14.2 93 31.6 0.14 (0.08–0.27) 0.01
Suprailiac skinfold thickness
<27.5 16 26.7 63 35.6 1.0 (reference) 23 17.7 14 12.0 1.0 (reference) 39 20.5 77 26.3 1.0 (reference)
≥27.5–<36.5 19 31.7 37 20.9 1.79 (0.77–4.16) 0.2 33 25.4 29 25.0 0.57 (0.23–1.39) 0.2 52 27.4 66 22.5 1.22 (0.69–2.16) 0.5
≥36.5–<45.5 17 28.3 38 21.5 1.16 (0.48–2.84) 0.7 36 27.7 35 30.2 0.53 (0.22–1.25) 0.1 53 27.9 73 24.9 0.94 (0.53–1.66) 0.8
≥45.5 8 13.3 39 22.0 0.44 (0.44–1.25) 0.1 38 29.2 38 32.8 0.49 (0.21–1.16) 0.1 46 24.2 77 26.3 0.78 (0.44–1.39) 0.4
Triceps skinfold thickness
<22 14 23.3 67 37.9 1.0 (reference) 13 10.0 25 21.6 1.0 (reference) 27 14.2 92 31.4 1.0 (reference)
≥22–<27 8 13.3 42 23.7 0.79 (0.29–2.15) 0.6 29 22.3 29 25.0 1.47 (0.61–3.56) 0.4 37 19.5 71 24.2 1.31 (0.71–2.42) 0.4
≥27–<33 19 31.7 42 23.7 1.89 (0.82–4.36) 0.1 38 29.2 28 24.1 1.98 (0.84–4.70) 0.1 57 30.0 70 23.9 1.92 (1.08–3.42) 0.03
≥33 19 31.7 26 14.7 2.64 (1.08–6.47) 0.03 50 38.5 34 29.3 2.24 (0.96–5.21) 0.06 69 36.3 60 20.5 2.56 (1.43–4.56) 0.01
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Table 3 Association between anthropometric measurements and breast cancer risk (Continued)
Subscapular skin-fold thickness
<23.7 17 28.3 60 33.9 1.0 (reference) 20 15.3 24 20.7 1.0 (reference) 37 19.4 84 28.7 1.0 (reference)
≥23.7–<31.5 11 18.3 54 30.5 0.62 (0.25–1.53) 0.3 22 16.8 32 27.6 0.69 (0.29–1.65) 0.4 33 17.3 86 29.3 0.64 (0.35–1.15) 0.1
≥31.5–<40 16 26.7 28 15.8 1.30 (0.52–3.24) 0.6 49 37.4 29 25.0 1.77 (0.78–4.03) 0.2 65 34.0 57 19.5 1.72 (0.98–3.02) 0.06
≥40 16 26.7 35 19.8 1.06 (0.43–2.57) 0.9 40 30.5 31 26.7 1.25 (0.55–2.85) 0.2 56 29.3 66 22.5 1.28 (0.73–2.26) 0.4
Wrist circumference
<15.5 9 16.4 50 28.4 1.0 (reference) 6 5.3 21 18.3 1.0 (reference) 15 8.9 71 28.4 1.0 (reference)
≥15.5–<16.25 17 30.9 60 24.1 0.72 (0.30–1.73) 0.5 26 23.7 23 20.0 0.83 (0.35–1.99) 0.7 44 26.0 83 28.5 0.84 (0.47–1.49) 0.5
≥16.25–<17 14 25.4 38 21.6 0.68 (0.26–1.78) 0.4 22 19.3 24 20.9 0.60 (0.25–1.44) 0.3 36 21.3 62 21.3 0.81 (0.44–1.50) 0.5
≥17 15 27.3 28 15.9 0.90 (0.32–2.49) 0.8 59 51.7 47 40.8 0.88 (0.41–1.89) 0.7 74 43.8 75 25.8 1.16 (0.66–2.04) 0.6
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Statistically significant differences in the thickness of
the skeleton between premenopausal and postmeno-
pausal women with breast cancer are an unusual finding
which has previously not been described in the litera-
ture. Compared to healthy individuals, breast cancer
women had elevated widths of the wrist, elbow, knee,
arm, and ankle and a bigger thorax. The most substan-
tial event during menopausal transition is decreasing
ovarian activity resulting in deficient estrogen levels. The
latter causes many menopausal symptoms such as a loss
of bone mass [25]. It is highly probable that in over-
weight women this situation is inverted. Constant higher
estrogen exposure during lifetime contributes to faster
bone maturation which begins in adolescence. There is
also an impact of the elevated level of IGF-1 (one of the
mitogenic factors) [26]. In adults, estrogen diminishes
bone resorption by inhibition of osteoclasts. In over-
weight women with breast cancer, this effect is amplified
by elevated levels of androgens which also have benefi-
cial effects on bone tissue [27]. Androgens act either by
conversion to estrogen via p450 aromatase enzyme
complex or by directly binding to androgen receptors.
Interestingly, androgens are responsible for the periosteal
expansion of bones which may be a direct explanation of
our findings [27]. However, it is necessary to mention that
central obesity leading to metabolic complications and
inflammation may be also associated with poor bone
health [28].
Study limitations and future research
The anthropometric measures used in the present study
have some limitations. Firstly, BMI is not a homogenous
parameter especially in comparison to modern tech-
niques used in order to assess fat distribution such as
the following: dual-energy X-ray absorptiometry (DXA),
bioelectrical impedance analysis (BIA), or air displacement
plethysmography. It may be misleading in individuals with
normal BMI but a high content of body fat. Secondly,
WHR may be also an inadequate index as it is under the
influence of confounding factors such as age-related
variation in muscle mass and tone.
Anthropometric measurements may be miscalculated
due to bias during examination (problems in taking
some measurements, non-cooperative patients, etc.).
The present results are confounded by variables such as
differences in age between groups, different stage of the
disease, and the method used for selecting the control
group. Nonetheless, the present results highlight signifi-
cant body parameter changes which could be of great
value in assessing breast cancer risk.
The present study highlighted some interesting avenues
of future research. The bone strengths between over-
weight breast cancer women are another area which has
yet to be explored in depth. Furthermore, the influence of
testosterone on breast tissue is an interesting issue par-
ticularly after consideration of its estrogen-independent
role which merits further investigation.
Conclusion
Obesity has reached an epidemic level. It should be a
matter of great concern due to the negative health
complications it is associated with such as higher cancer
rates. Our study revealed that women with breast cancer
present with a typical android silhouette and visceral
obesity, which is more common in men, along with
altered body proportions and increased thickness of the
skeleton. Some simple anthropometric characteristics
(WHR; BMI; skinfold thicknesses; widths of shoulders,
elbow, ankle, and wrist; and circumferences of thigh and
wrist) and the estimation of body proportions may be a
valuable tool for women assessment in order to disclose
groups at a higher risk of developing breast cancer in
the future.
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